Octreotide Long-Acting Release

octreotide long-acting release · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octreotide Long-Acting Release, covering 2009-08-06 to 2009-08-06. Get the full timeline:

Most recent: Clinical Trial Update: 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors [Phase 2]